Tokyo Tape
Sign in

Daito Pharmaceutical

4577.TPharmaceutical
Filed as Daito Pharmaceutical Co.,Ltd. (2022-08–2026-08)
In English · 5
Tue, Nov 10 · JST1 filing
16:035% STAKEDaito Pharmaceutical · Kaname Capital, L.P. · 11.13% → 12.13%+1.00pp
Tue, Oct 13 · JST1 filing
16:075% STAKEDaito Pharmaceutical · Kaname Capital, L.P. · 11.13% → 12.13%+1.00pp
Tue, Aug 12 · JST1 filing
11:415% STAKEDaito Pharmaceutical · Kaname Capital, L.P. · 9.98% → 11.13%+1.15pp
Fri, Jan 17 · JST1 filing
17:04MATERIALDaito Pharmaceutical · Change in parent company or specified subsidiary
Wed, Aug 28 · JST1 filing
16:43MATERIALDaito Pharmaceutical · Change in major shareholder
All EDINET filings · 89
AllFinancial 355% 25Material 5Other 24
FiledDocumentFilerSource
2026-08-31Material event reportDaito Pharmaceutical Co., Ltd.S100YZH9
2026-08-26CEO/CFO certificationDaito Pharmaceutical Co., Ltd.S100YYNK
2026-08-26Internal control reportDaito Pharmaceutical Co., Ltd.S100YYNJ
2026-08-26Annual reportDaito Pharmaceutical Co., Ltd.S100YYNI
2026-08-06Share buyback reportDaito Pharmaceutical Co., Ltd.S100YUK8
2026-06-11Share buyback reportDaito Pharmaceutical Co., Ltd.S100YAFD
2026-05-12Share buyback reportDaito Pharmaceutical Co., Ltd.S100Y30S
2026-04-10Share buyback reportDaito Pharmaceutical Co., Ltd.S100XXXR
2026-03-12Share buyback reportDaito Pharmaceutical Co., Ltd.S100XQ8L
2026-02-12Share buyback reportDaito Pharmaceutical Co., Ltd.S100XKJR
2026-02-04Large shareholding reportRelated to S100NOS2Masachusettsu Fainansharu Sabisezu KanpaniS100XIZW
2026-01-14CEO/CFO certificationDaito Pharmaceutical Co., Ltd.S100XFIN
2026-01-14Half-year reportDaito Pharmaceutical Co., Ltd.S100XFIM
2026-01-13Share buyback reportDaito Pharmaceutical Co., Ltd.S100XFAW
2025-12-11Share buyback reportDaito Pharmaceutical Co., Ltd.S100X9E7
2025-11-13Share buyback reportDaito Pharmaceutical Co., Ltd.S100X2X9
2025-09-01Material event reportDaito Pharmaceutical Co., Ltd.S100WMBR
2025-08-27CEO/CFO certificationDaito Pharmaceutical Co., Ltd.S100WLN4
2025-08-27Internal control reportDaito Pharmaceutical Co., Ltd.S100WLN3
2025-08-27Annual reportDaito Pharmaceutical Co., Ltd.S100WLMY
2025-08-15Amended large shareholding reportAmends S100WI7SKaname Kapitaru ErupiS100WJ75
2025-08-12Large shareholding reportRelated to S100U9IJKaname Kapitaru ErupiS100WI7S
2025-06-06Large shareholding reportRelated to S100U9IJKaname Kapitaru ErupiS100VWCS
2025-01-17Material event reportDaito Pharmaceutical Co., Ltd.S100V3T4
2025-01-10CEO/CFO certificationDaito Pharmaceutical Co., Ltd.S100V2QT
2025-01-10Half-year reportDaito Pharmaceutical Co., Ltd.S100V2QQ
2024-09-02Material event reportDaito Pharmaceutical Co., Ltd.S100UB4I
2024-08-30CEO/CFO certificationDaito Pharmaceutical Co., Ltd.S100UAWZ
2024-08-30Internal control reportDaito Pharmaceutical Co., Ltd.S100UAWY
2024-08-30Annual reportDaito Pharmaceutical Co., Ltd.S100UAWW

EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 22 financial reports not structured yet.

Not structured yet
2022-02-28quarterlyoriginal indexedS100NW91
2021-11-30quarterlyoriginal indexedS100N848
2021-08-31quarterlyoriginal indexedS100MLNW
2021-05-31annualoriginal indexedS100MCBH
2021-02-28quarterlyoriginal indexedS100L64R
2020-11-30quarterlyoriginal indexedS100KIYJ
2020-08-31quarterlyoriginal indexedS100JWUL
2020-05-31annualoriginal indexedS100JM33
2020-02-29quarterlyoriginal indexedS100IFUF
2019-11-30quarterlyoriginal indexedS100HQGW
2019-08-31quarterlyoriginal indexedS100H4GK
2019-05-31annualoriginal indexedS100GVBD
2019-02-28quarterlyoriginal indexedS100FM1O
2018-11-30quarterlyoriginal indexedS100EWUI
2018-08-31quarterlyoriginal indexedS100E9VK
2018-05-31annualoriginal indexedS100E117
2018-02-28quarterlyoriginal indexedS100CS7V
2017-11-30quarterlypending downloadS100C3J6
2017-08-31quarterlypending downloadS100BHOW
2017-05-31annualpending downloadS100B94K
2017-02-28quarterlypending downloadS100A2VP
2016-11-30quarterlypending downloadS1009FS2